CHRS
Coherus Oncology·NASDAQ
--
--(--)
--
--(--)
2.21 / 10
Underperform
Technical indicators are underwhelming: the 2.21/10 score reflects dominant bearish signals (Long Lower and Upper Shadows) with no bullish indicators present, suggesting continued downside risk in the near term.
Analysis Checks(0/2)
Long Lower Shadow
Score1.02/10
Win Rate39.53%
Hist. Signals43
Avg Return-0.82%
Score1.02/10
Win Rate39.53%
Hist. Signals43
Avg Return-0.82%
Long Upper Shadow
Score3.41/10
Win Rate50.72%
Hist. Signals69
Avg Return0.60%
Score3.41/10
Win Rate50.72%
Hist. Signals69
Avg Return0.60%
Long Lower Shadow
Score1.02/10
Win Rate39.53%
Hist. Signals43
Avg Return-0.82%
Score1.02/10
Win Rate39.53%
Hist. Signals43
Avg Return-0.82%
Long Upper Shadow
Score3.41/10
Win Rate50.72%
Hist. Signals69
Avg Return0.60%
Score3.41/10
Win Rate50.72%
Hist. Signals69
Avg Return0.60%
What is the current technical signals for CHRS?
- CHRS presents a Underperform setup with a Technical Score of 2.21/10. Key technical indicators highlight an RSI of 59.31 and a MACD of -0.00, with the trend anchored by the 50-Day SMA at 1.59. Traders should monitor key support at 2.03 and resistance at 2.20.
